Allergy & Immunology

Peanut oral immunotherapy (POIT), which involves gradually increasing exposure to peanut protein, has shown promise, successfully desensitising 50–70% of patients.

A recent landmark study is the first randomised, controlled trial to show clinical benefits of an allergy app for SAR sufferers.

In a new study, researchers identified a specific immune cell type, CD4+ T follicular helper (Tfh) cells producing IL-21 and IFN-γ, as a key driver of ICI-T1DM.

Discover a study linking everyday plastic chemicals to increased risks of asthma, wheezing, and allergies in young children.

Traditionally, FA management has focused on avoidance or reducing allergenicity by altering the protein structure of allergens through heat, pressure or other treatments.

The findings provide genetic evidence supporting the theory that the nervous and immune systems may interact more closely in children with ADHD.

Researchers analysed antibiotic prescriptions for a 15-month period after discharge, comparing patients with and without penicillin allergies.

One in four U.S. infants lacks Bifidobacterium, a key gut microbe essential for immune and metabolic health.